Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Return on Equity %

Rigel Pharmaceuticals Return on Equity % Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Return on Equity % from 2010 to 2020.
  • Rigel Pharmaceuticals Return on Equity % for the quarter ending September 09, 2020 was -99.32 a -12.88% increase of 12.80 year over year
  • Rigel Pharmaceuticals Return on Equity % for the last 12 months ending September 09, 2020 was -46.23 a -76.79% increase of 35.50 year over year
  • Rigel Pharmaceuticals Annual Return on Equity % for 2019 was -81.73 a 18.08% decrease of -14.77 from 2018
  • Rigel Pharmaceuticals Annual Return on Equity % for 2018 was -66.96 a -49.65% increase of 33.24 from 2017
  • Rigel Pharmaceuticals Annual Return on Equity % for 2017 was -100.20 a 5.64% decrease of -5.65 from 2016
Other Margins & Efficiency Metrics:
  • Rigel Pharmaceuticals EBITDA Margin for the quarter ending December 12, 2018 was $7m a 801.93% increase of 57m year over year
  • Rigel Pharmaceuticals Return on Capital % for the quarter ending September 09, 2018 was -53.67 a -55.75% increase of 29.92 year over year
View Chart On Koyfin

Quarterly RIGL Return on Equity % Data

09/2020-99.32
06/2020-99.22
03/2020128.44
12/2019-112.12
09/2019-62.44
06/2019-94.96
03/2019-68.61
12/201812.10
09/2018-83.74
06/2018-100.53

Annual RIGL Return on Equity % Data

2019-81.73
2018-66.96
2017-100.20
2016-94.55
2015-46.86
2014-54.03
2013-35.80
2012-37.64
2011-42.74
201027.46